17 reports

filgrastim) Pegasys (PEGylated interferon) Perjeta Pulmozyme (dornase alfa) Roaccutane/ Accutane (isotretinoin) RoACTEMRA (tocilizumab) Rocaltrol (calcitriol) Rocephin (ceftriaaxone) Roferon-A (interferon alfa-##a) Tamiflu (oseltamivir) Tarceva (erlotinib) Toradol (ketorolac) Valcyte (va

  • Drug Delivery
  • United States
  • World
  • Market Size
  • Pfizer Inc.

United States Biopsy Devices Market Outlook to 2023 Healthcare REPORT CODE: GDMECC##DB PUBLISHED: MARCH 2017 ## Introduction Medical Equipment Market Reports are the ideal guide for anyone wishing to understand their market better in terms of revenues, unit sales, distributors and competitors.

  • Biopsy
  • Drug Delivery
  • Injectable Delivery
  • United States
  • Vascular Solutions, Inc.

Filgrastim Product Abbvie Company Amgen The growth of the injectable drug delivery market is mainly driven by generic injectables.

  • Drug Delivery
  • Europe
  • World
  • Market Size
  • Gerresheimer AG

INFUSION (AN ANTIBODY DRUG), AND FILGRASTIM BS INJ.

  • Drug Delivery
  • Asia
  • Japan
  • Market Size
  • Pfizer Inc.
  • Chapter 6 - Drug Delivery dealmaking by technology type

filgrastim and pegfilgrastim No Oct 2013 No Oct 2013 InnoCore Technologies, Allergan No Oct 2013 Amgen, Roche Marketed No Oct 2013 Ablynx, Eddingpharm Phase I ##. ## Licensing agreement for anti- rankl nanobody, ALX-## Marketing and distribution agreement for Brinavess (vernakalant intraveno

  • Drug Delivery
  • Pharmaceutical
  • Therapy
  • United States

Global sales of Biopharmaceuticals (including biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew +##% (cc) to USD ## million, driven by strong performance of Zarxio (filgrastim) and Glatopa ##mg in the US.

  • Drug Delivery
  • Therapy
  • United States
  • Company Financials
  • GlobalData's company
  • 5.2 MARKET DYNAMICS

SANDOZ LAUNCHED ZARXIO (FILGRASTIM-SNDZ) IN THE U. S.

  • Drug Delivery
  • North America
  • World
  • Market Size
  • Sanofi S.A.

Global sales of Biopharmaceuticals (including biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew +##% (cc) to USD ## million, driven by strong performance of Zarxio (filgrastim) and Glatopa ##mg in the US.

  • Drug Delivery
  • Respiratory Treatment
  • United States
  • Company Financials
  • GlobalData's company

ID=##& DATE=2016-##-##) ## FILGRASTIM BIOSIMILAR ##SOURCE:HTTP:/ / WWW. EMA. EUROPA. EU/ EMA/ INDEX. JSP?

  • Drug Delivery
  • World
  • Market Size
  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.

Global sales of Biopharmaceuticals (including biosimilars, biopharmaceutical contract manufacturing and Glatopa) grew +##% (cc) to USD ## million, driven by strong performance of Zarxio (filgrastim) and Glatopa ##mg in the US.

  • Drug Delivery
  • Respiratory Treatment
  • United States
  • Company Financials
  • GlobalData's company
  • RECALL OF DEVICES (AUTOINJECTORS AND PREFILLED SYRINGES)
  • SWOT ANALYSIS

QU=NEULASTA+FILGRASTIM& KID=##& T=NEULASTA& F=DRUGS& NEWS=##& PAGE=## ## SOURCE: HTTPS:/ / WWW. CDC. GOV/ H##N##FLU/ VACCINATION/ SYRINGES_QA. HTM ## SMARTJECT® IS A REGISTERED TRADEMARK OF JOHNSON & JOHNSON ## SOURCE: HTTP:/ / PHARMACYSERVICES.

  • Drug Delivery
  • Debiotech S.A.
  • Medtronic, Inc.
  • Roche Group
  • West Pharmaceutical Services, Inc.

Filgrastim Filgrastim Filgrastim Filgrastim BS Filgrastim BS Filgrastim BS The Japanese biotech market is somewhat nascent; the next ## years, to 2019, will be key, if key domestic institutions and investors can get their products to the global ma

  • Drug Delivery
  • World
  • Baxter International Inc.
  • Merck & Co., Inc.
  • Novo Nordisk Group

The company' s key products include Neulasta (pegfilgrastim); Neupogen (filgrastim) indicated for cancer treatment; Enbrel (entanercept) for treating rheumatoid arthritis; Epogen (Erythropoietic Stimulating Agents); Aranesp (darbepoetin alfa) to treat anemia associated with chronic kidn

  • Drug Delivery
  • Pharmaceutical
  • North America
  • United States
  • Pfizer Inc.

IN ADDITION, INTAS IS ALSO THE ONLY COMPANY FROM INDIA TO HAVE TWO OF ITS BIOSIMILARS, FILGRASTIM AND PEG-FILGRASTIM FILED FOR REGISTRATION IN THE US.

  • Drug Delivery
  • North America
  • United States
  • Forecast
  • Market Size

Report Title Published Date ## Biosimilars Market - By Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Trends & Global Fore

  • Drug Delivery
  • Europe
  • World
  • Market Size
  • Novo Nordisk Group

CASE STUDY: NEULASTA (AMGEN) Neulasta (pegfilgrastim) is composed of recombinant human granulocyte colony stimulating factor (G-CSF) or filgrastim conjugated to monomethoxypolyethylene glycol.

  • Drug Delivery
  • Adocia
  • Alnylam Pharmaceuticals, Inc.
  • Biologics, Inc.
  • Halozyme Therapeutics, Inc.
  • Month & Year
  • Untitled

Teva received the FDA approval for GRANIX (tbo-filgrastim) which is used to reduce severe neutropenia in patients.

  • Drug Delivery
  • Europe
  • World
  • Market Size
  • Pfizer Inc.